| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$77 |
Capital Raising Presentation
|
23 Jul 2025 9:54AM |
$0.285 |
$0.150 |
fallen by
47.37%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- Amplia Therapeutics Limited is undertaking a capital raising to fund the development of its lead drug, AMP945, an FAK inhibitor for cancer therapy.
- The capital raising is structured as a placement and rights issue for new shares.
- Funds raised will primarily be used for clinical trials, operational costs, and advancing AMP945 development, particularly in pancreatic cancer.
- Recent achievements include positive data from clinical studies and progression of AMP945 towards later-phase trials.
- The company outlines milestones and timelines for future clinical and regulatory activities.
- Additional indications for AMP945 and pipeline expansion are discussed.
- Details on share issuance, investor eligibility, offer terms, and schedule are provided.
- Key risks and forward-looking statements are disclosed to inform potential investors.
- Use of proceeds is projected to cover clinical trials, regulatory submissions, and working capital.
- Amplia’s management and board are highlighted, emphasizing their experience in biotech and drug development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Catalina Resources Ltd (CTN) ORDINARY FULLY PAID |
Materials |
$8 |
Fieldwork Underway at Evanstone & Yerilgee
|
23 Jul 2025 9:54AM |
$0.005 |
$0.045 |
risen by
900%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$77 |
Proposed issue of securities - ATX
|
23 Jul 2025 9:53AM |
$0.285 |
$0.150 |
fallen by
47.37%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$77 |
Proposed issue of securities - ATX
|
23 Jul 2025 9:53AM |
$0.285 |
$0.150 |
fallen by
47.37%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$77 |
Proposed issue of securities - ATX
|
23 Jul 2025 9:53AM |
$0.285 |
$0.150 |
fallen by
47.37%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$77 |
Amplia announces A$25m Placement and Launches A$2.5m SPP
|
23 Jul 2025 9:53AM |
$0.285 |
$0.150 |
fallen by
47.37%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- Amplia Therapeutics Limited announced a A$25 million capital raising via a Placement to institutional and sophisticated investors.
- A Share Purchase Plan (SPP) has been launched to raise up to an additional A$2.5 million from eligible existing shareholders.
- The funds raised will be used to accelerate the clinical development of AMP945, Amplia’s lead drug candidate.
- Key focus areas include advancing AMP945 in combination with gemcitabine and Abraxane for pancreatic cancer treatment.
- Proceeds will also be used to support ongoing clinical trials, business development, and general working capital.
- The Placement was strongly supported by new and existing investors.
- The SPP will offer shares to eligible shareholders at the same price as the Placement.
- Amplia’s Board and management believe the additional funding will enable significant progress in clinical and corporate activities.
- The announcement outlines expected timelines for capital deployment and further milestones.
- The company thanks shareholders for their ongoing support and confidence in the Amplia business strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Codeifai Limited (CDE) ORDINARY FULLY PAID |
Industrials |
$8 |
Former NVIDIA A.I. Pioneer Appointed to Advisory Panel
|
23 Jul 2025 9:52AM |
$0.018 |
$0.008 |
fallen by
55.56%
|
|
| IperionX Limited (IPX) ORDINARY FULLY PAID |
Materials |
$1,422 |
June 2025 Quarterly Report
|
23 Jul 2025 9:49AM |
$5.300 |
$4.190 |
fallen by
20.94%
|
|
IPX - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of Phase 2 drilling at the Muckanippie Project significantly expanded the scale of the Rosewood Titanium Discovery.
- Heavy mineral (HM) mineralisation now extends over an area exceeding 20 square kilometres and remains open, particularly to the north.
- Phase 3 drill program completed, comprising 110 holes for 3,231 meters, with results expected in the next quarter.
- Two distinct, high-grade north-south trending mineralised zones identified at Rosewood East and West.
- Bulk sample metallurgical test work initiated to assess processing pathways and potential product specifications.
- Petratherm has earned a 51% interest in tenement EL 6715 and aims to increase this to 70%.
- Mr. Rob Sennitt appointed as Executive Director, contributing over 30 years of experience in the resources sector.
- The company held $8.4 million in cash at the end of the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IperionX Limited (IPX) ORDINARY FULLY PAID |
Materials |
$1,422 |
June 2025 Quarterly Report
|
23 Jul 2025 9:49AM |
$5.300 |
$4.190 |
fallen by
20.94%
|
|
IPX - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of the Titanium Manufacturing Campus in Virginia.
- Recognition by the U.S. Government with an SBIR Phase III IDIQ contract.
- Strong financial position with $54.8 million cash on hand at end of June 2025.
- Private placement raising $46 million to accelerate production expansion.
- Focus on sustainable, low-cost titanium production.
- Strategic customer partnerships in automotive, aerospace, and defense sectors.
- U.S. Government funding commitments driving production scale-up.
- Development of the Titan Critical Minerals Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pilot Energy Limited (PGY) ORDINARY FULLY PAID |
Energy |
$7 |
Pilot commences Perth Basin exploration farmout
|
23 Jul 2025 9:47AM |
$0.010 |
$0.054 |
risen by
440%
|
|
PGY - Price-sensitive ASX Announcement
Full Release
Key Points
- Pilot Energy Limited initiates a farmout process for Perth Basin exploration permits EP416 and EP480.
- The company is seeking a partner to advance gas exploration and development in the region.
- The Perth Basin assets are highlighted as highly prospective for natural gas.
- The farmout aims to unlock value and support Pilot’s broader energy transition strategy.
- Recent technical and geological studies underpin the potential of the permits.
- There is a growing demand for gas in Western Australia, supporting the market opportunity.
- The farmout aligns with Pilot’s focus on both traditional energy and renewable projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Rare Earths Limited (AR3) ORDINARY FULLY PAID |
Materials |
$28 |
Corporate Presentation - July 2025
|
23 Jul 2025 9:45AM |
$0.096 |
$0.110 |
risen by
15.18%
|
|
| Golden Horse Minerals Limited (GHM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$122 |
First Diamond Drillhole Intersects High-Grade Mineralisation
|
23 Jul 2025 9:43AM |
$0.420 |
$0.480 |
risen by
14.29%
|
|
GHM - Price-sensitive ASX Announcement
Full Release
Key Points
- GHM announced the initial results from the first diamond drillhole at the Pilot Prospect.
- The drillhole intersected high-grade gold and copper mineralisation.
- Results confirm the prospectivity of the Pilot Prospect within GHM's tenements.
- The drilling validates the company's targeted exploration strategy.
- Further drilling is planned to expand and delineate the mineralised zones.
- GHM is committed to systematic exploration and value creation for shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TechGen Metals Ltd (TG1) ORDINARY FULLY PAID |
Materials |
$9 |
Copper Gold Portfolio Advancement
|
23 Jul 2025 9:43AM |
$0.024 |
$0.020 |
fallen by
16.67%
|
|
TG1 - Price-sensitive ASX Announcement
Full Release
Key Points
- TechGen Metals Ltd is progressing exploration activities in its Copper Gold Portfolio.
- Recent drilling and geochemical surveys have identified new copper and gold anomalies.
- The company’s portfolio comprises projects in Western Australia and New South Wales.
- Exploration results have demonstrated significant potential for future resource growth.
- TG1’s strategy includes systematic exploration, resource definition, and follow-up drilling.
- Ongoing and planned work programs aim to advance existing projects and explore new targets.
- The company is focused on enhancing project value and delivering results to shareholders.
- Results and updates are based on the latest field campaigns and technical assessments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lake Resources NL (LKE) ORDINARY FULLY PAID |
Materials |
$107 |
$2.1 Million At-the-Market Facility Raise
|
23 Jul 2025 9:42AM |
$0.038 |
$0.046 |
risen by
21.05%
|
|
LKE - Price-sensitive ASX Announcement
Full Release
Key Points
- Lake Resources NL (LKE) announced it has raised approximately $2.1 million via an at-the-market (ATM) facility.
- The funds were raised under the previously established ATM facility, which allows the company to issue new shares to raise capital as needed.
- This capital raise is intended to support ongoing activities and operations, providing additional financial flexibility.
- The ATM facility enables LKE to raise funds efficiently and at its discretion, depending on market conditions and company requirements.
- No shareholder approval was required for this use of the ATM facility, as it falls within the company's existing placement capacity.
- The raised funds will be used to support the company's lithium project developments and general working capital needs.
- Lake Resources continues to progress its flagship Kachi Lithium Brine Project in Argentina.
- The company aims to maintain momentum in project development and advance towards its production goals.
- LKE remains focused on delivering value for shareholders through the development of its lithium assets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bowen Coking Coal Limited (BCB) ORDINARY FULLY PAID |
Materials |
$8 |
QRO State Royalty Deferral Proposal Declined
|
23 Jul 2025 9:42AM |
$0.075 |
$0.075 |
fallen by
0%
|
|
| Maronan Metals Limited (MMA) ORDINARY FULLY PAID |
Materials |
$137 |
Noosa Mining Conference 2025 Presentation
|
23 Jul 2025 9:40AM |
$0.230 |
$0.435 |
risen by
89.13%
|
|
| Lord Resources Limited (LRD) ORDINARY FULLY PAID |
Materials |
$3 |
Investor Presentation - Noosa Mining Conference
|
23 Jul 2025 9:40AM |
$0.031 |
$0.015 |
fallen by
51.61%
|
|
| Meteoric Resources NL (MEI) ORDINARY FULLY PAID |
Materials |
$480 |
Proposed issue of securities - MEI
|
23 Jul 2025 9:39AM |
$0.155 |
$0.165 |
risen by
6.45%
|
|
| Latrobe Magnesium Limited (LMG) ORDINARY FULLY PAID |
Materials |
$47 |
Response to ASX Price Query
|
23 Jul 2025 9:39AM |
$0.016 |
$0.015 |
fallen by
6.25%
|
|
LMG - Price-sensitive ASX Announcement
Full Release
Key Points
- ASX queried Latrobe Magnesium Limited (LMG) regarding a significant increase in its share price and trading volumes.
- LMG responded that it is not aware of any information not previously announced to the market that could explain the recent trading activity.
- The company confirmed it is in compliance with ASX Listing Rules, particularly Listing Rule 3.1 concerning continuous disclosure obligations.
- LMG acknowledged that it is in the process of preparing an ASX announcement related to the progress of its magnesium demonstration plant but stated that this does not explain the recent price movements.
- LMG's board and management reiterated their commitment to transparency and prompt disclosure of any material developments.
- The company confirmed it does not have any other explanation for the unusual trading other than previously disclosed information.
- LMG will continue to comply with its disclosure obligations and monitor any further unusual market activity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Meteoric Resources NL (MEI) ORDINARY FULLY PAID |
Materials |
$480 |
Strong Market Support Underpins $42.5M Placement
|
23 Jul 2025 9:39AM |
$0.155 |
$0.165 |
risen by
6.45%
|
|
MEI - Price-sensitive ASX Announcement
Full Release
Key Points
- Meteoric Resources NL raised AU$42.5 million via a placement to institutional and sophisticated investors.
- Funds will be used to advance the Caldeira Rare Earth Project in Brazil including feasibility studies and engineering.
- Strong support was received from both new and existing shareholders.
- The placement was conducted at a price representing a modest discount to recent trading prices.
- Funds are targeted to accelerate project activities and reach key milestones.
- The announcement includes details on the placement structure, allocation, and anticipated timeline for project progress.
- Meteoric’s board and management expressed confidence in the project’s outlook and thanked investors for their support.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IperionX Limited (IPX) ORDINARY FULLY PAID |
Materials |
$1,422 |
Proposed issue of securities - IPX
|
23 Jul 2025 9:39AM |
$5.300 |
$4.190 |
fallen by
20.94%
|
|
| IperionX Limited (IPX) ORDINARY FULLY PAID |
Materials |
$1,422 |
IperionX Secures A$70M to Accelerate US Titanium Production
|
23 Jul 2025 9:38AM |
$5.300 |
$4.190 |
fallen by
20.94%
|
|
IPX - Price-sensitive ASX Announcement
Full Release
Key Points
- IperionX secures A$70 million for US titanium production expansion.
- The capital will expedite the ordering of long-lead capital items.
- This move supports the US defense and aerospace sectors.
- Engagement with the US Department of Defense may unlock additional funding.
- Execution of the placement in two tranches with Petra Capital Pty Limited as Lead Manager.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Albion Resources Limited (ALB) ORDINARY FULLY PAID |
Materials |
$7 |
Trading Halt
|
23 Jul 2025 9:38AM |
$0.069 |
$0.049 |
fallen by
28.99%
|
|
ALB - Price-sensitive ASX Announcement
Full Release
Key Points
- Albion Resources Limited requested a trading halt on 11 June 2024.
- The trading halt is pending an announcement about a material acquisition and capital raising.
- The halt is to ensure a fully informed market and maintain orderly trading.
- The trading halt will end on the earlier of 13 June 2024 or when the announcement is made.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aerometrex Limited (AMX) ORDINARY FULLY PAID |
Industrials |
$27 |
AMX Completes Strategic Review Unlocks Growth, Cuts Costs
|
23 Jul 2025 9:37AM |
$0.210 |
$0.280 |
risen by
33.33%
|
|
AMX - Price-sensitive ASX Announcement
Full Release
Key Points
- Aerometrex (AMX) completed a strategic review to unlock growth and reduce costs.
- Refocus on core business segments, especially MetroMap and 3D products.
- Significant cost reductions including staff cuts and expense rationalization.
- Annualized cost savings expected from the implemented measures.
- Continued pursuit of U.S. market and international growth opportunities.
- Board and executive changes have been made to support the new focus.
- Commitment to innovation, customer value, and sustainable future growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID |
Health Care |
$750 |
IDX FY25 Results Conference Call
|
23 Jul 2025 9:37AM |
$2.770 |
$2.010 |
fallen by
27.44%
|
|
Call 1300 880 160
Start a chat
Schedule a call
